Acute Pancreatitis Market to Grow with a CAGR of 5.03% through 2028
Rising prevalence of obesity and gallstone diseases are
expected to drive the Global Acute Pancreatitis Market growth in the forecast
period, 2024-2028.
According to TechSci Research report, “Acute
Pancreatitis Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Acute Pancreatitis Market
stood at USD 5.10 billion in 2022 and is anticipated to grow with a CAGR of 5.03%
in the forecast period, 2024-2028. The global acute pancreatitis market is
undergoing a significant transformation, driven by a multitude of factors that
are reshaping the landscape of diagnosis, treatment, and management of this
severe pancreatic condition. Acute pancreatitis is a painful and potentially
life-threatening inflammation of the pancreas, and its increasing prevalence is
a growing concern worldwide. Unhealthy dietary habits, high consumption of
alcohol, and a rise in obesity rates have all been identified as significant
risk factors for acute pancreatitis. As these lifestyle-related issues become
more prevalent, the number of individuals at risk for acute pancreatitis also
increases, driving the demand for diagnosis, treatment, and management of the
condition. Early and accurate diagnosis of acute pancreatitis is
crucial for effective management and improved patient outcomes. The market has
witnessed substantial advancements in diagnostic techniques, including imaging
studies such as CT scans and MRI, as well as blood tests that can help
healthcare professionals diagnose and assess the severity of the condition.
These innovations have led to quicker and more precise diagnoses, contributing
to the overall growth of the market. Treatment of acute pancreatitis has seen significant
technological advancements. Endoscopic techniques, minimally invasive
procedures, and the development of novel drugs and therapies have enhanced the
options available to healthcare professionals. These innovations not only
improve patient care but also boost the market's growth as healthcare providers
adopt these advanced treatment modalities.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Acute Pancreatitis Market.”
The increasing global healthcare expenditure is
another key driver of the acute pancreatitis market. As governments and private
institutions allocate more resources to healthcare infrastructure, there is
greater accessibility to specialized care for acute pancreatitis patients. This
includes better-equipped hospitals, skilled medical professionals, and improved
healthcare services, all of which contribute to the growth of the market.
The Global Acute Pancreatitis Market is segmented into
Treatment, Diagnosis, End-User, Regional Distribution, And Company.
Based on the Treatment, Nutritional
Support emerged as the dominant segment in the global market for Global Acute
Pancreatitis Market in 2022. adequate nutrition is essential for the healing
process, as it supports tissue repair and reduces the risk of complications.
Malnourished patients with acute pancreatitis are at a higher risk of infection
and delayed recovery. Malnutrition can exacerbate the severity of acute
pancreatitis and increase the likelihood of developing complications, such as
infected pancreatic necrosis. Providing nutritional support helps reduce these
risks. Nutritional support can also aid in pain management. It can help reduce
pancreatic stimulation, as oral intake of food triggers pancreatic enzyme
secretion. By providing nutrition through alternative routes, such as enteral
or parenteral feeding, patients can experience reduced pain associated with
oral intake. Patients receiving proper nutrition tend to recover more
quickly, spend fewer days in the hospital, and have better long-term outcomes.
This not only benefits patients but also reduces the economic burden on
healthcare systems.
Based on the Diagnosis, the Imaging tests segment
emerged as the dominant player in the global market for Global Acute
Pancreatitis Market in 2022. Imaging tests, such as computed tomography (CT)
scans, magnetic resonance imaging (MRI), and ultrasound, provide visual
confirmation of pancreatic inflammation and any associated complications. These
tests offer a direct view of the pancreas, allowing healthcare professionals to
assess the extent of inflammation, presence of necrosis, and other
abnormalities. Imaging tests are instrumental in achieving a rapid diagnosis of
acute pancreatitis. They provide immediate visual evidence of the condition,
which is particularly important in severe cases where early intervention is
crucial. Prompt diagnosis enables healthcare providers to initiate treatment
promptly, improving patient outcomes.
Based on the End-User, the Hospitals and clinics segment
emerged as the dominant player in the global market for Global Acute
Pancreatitis Market in 2022. Hospitals, especially tertiary care hospitals,
have specialized departments and units, including gastroenterology and surgical
departments, equipped to provide comprehensive care for acute pancreatitis.
These facilities offer access to a wide range of medical specialists and
resources needed to manage complex cases effectively. Hospitals typically have
advanced diagnostic facilities, such as computed tomography (CT) scanners,
magnetic resonance imaging (MRI) machines, and well-equipped laboratories,
which are essential for accurate and timely diagnosis of acute pancreatitis.
These diagnostic tools play a crucial role in guiding treatment decisions.
Hospitals
have ICUs with the specialized equipment and personnel necessary to care for
critically ill patients with acute pancreatitis. Severe cases may require
intensive monitoring, mechanical ventilation, and other critical care
interventions, which are readily available in hospital settings.
North America emerged as the dominant player in the
global Acute Pancreatitis Market in 2022, holding the largest market share.
North America boasts a highly advanced and well-developed healthcare infrastructure.
The region is home to world-class hospitals, clinics, and medical facilities,
equipped with state-of-the-art diagnostic and treatment technologies. This
infrastructure is pivotal in providing efficient and effective care for acute
pancreatitis patients. North America is home to specialized pancreas centers
and facilities dedicated to the treatment of pancreatic disorders, including
acute pancreatitis. These centers offer comprehensive care and access to
cutting-edge treatments and clinical trials. North America has a vast pool of
healthcare professionals with specialized expertise in treating acute
pancreatitis. Gastroenterologists, pancreatologists, surgeons, and other
specialists are readily available to diagnose and manage the condition, ensuring
that patients receive high-quality care.
Major companies operating in Global Acute
Pancreatitis Market are:
- SCM Lifescience
- GNT Pharma Co
- Baxter International Inc.
- B. Braun Melsungen AG
- General Electric Company
- Medtronic Plc
- Boston Scientific Corporation
- Fresenius Kabi USA
- McNeil Consumer Healthcare
- Sun BioPharma
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Global
Acute Pancreatitis Market is poised for significant growth in the coming years.
Anticipated factors driving this expansion include increasing awareness and
early diagnosis of the condition, technological advancements in diagnostic
tools and treatment modalities, and a growing prevalence of risk factors such
as obesity and gallstone disease. The market will also benefit from ongoing
research and innovation, leading to the development of novel drug therapies and
minimally invasive surgical techniques. Furthermore, the aging global
population, with a higher susceptibility to acute pancreatitis, will contribute
to the market's growth as healthcare systems adapt to the unique needs of
elderly patients. As healthcare access and insurance coverage improve in
various regions, patients will seek timely medical attention, fostering demand
for acute pancreatitis-related services.” said Mr. Karan Chechi, Research
Director with TechSci Research, a research-based management consulting firm.
“Acute Pancreatitis Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By
Treatment (Intravenous Fluid, Nutritional Support, Analgesics, Endoscopic
Retrograde Cholangiopancreatography (ERCP), Other treatments), By Diagnosis
(Imaging tests, Laboratory Tests), By End-User (Hospitals & Clinics,
Ambulatory care Centers, Others) By Region and Competition”, has evaluated
the future growth potential of Global Acute Pancreatitis Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Acute Pancreatitis Market.
Contact
Mr. Ken
Mathews
708 Third
Avenue,
Manhattan, NY,
New York –
10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com